Literature for peptidase C01.036: cathepsin K

(References are filtered for relevance to Structure. To remove the filter click here. See explanation.)

2018
1. Roy,S., Das Chakraborty,S. and Biswas,S.
   Not all pycnodysostosis-related mutants of human cathepsin K are inactive - crystal structure and biochemical studies of an active mutant I249T
   FEBS J (2018) 285, 4265-4280. PubMed  Europe PubMed DOI  M  S
2017
2. Law,S., Andrault,P.M., Aguda,A.H., Nguyen,N.T., Kruglyak,N., Brayer,G.D. and Bromme,D.
   Identification of mouse cathepsin K structural elements that regulate the potency of odanacatib
   Biochem J (2017) 474, 851-864. PubMed  Europe PubMed DOI  S  I
2014
3. Novinec,M., Korenc,M., Caflisch,A., Ranganathan,R., Lenarcic,B. and Baici,A.
   A novel allosteric mechanism in the cysteine peptidase cathepsin K discovered by computational methods
   Nat Commun (2014) 5, 3287-3287. PubMed  Europe PubMed DOI  S  I
2013
4. Yuan,X.Y., Fu,D.Y., Ren,X.F., Fang,X., Wang,L., Zou,S. and Wu,Y.
   Highly selective aza-nitrile inhibitors for cathepsin K, structural optimization and molecular modeling
   Org Biomol Chem (2013) 11, 5847-5852. PubMed  Europe PubMed DOI  S  I
2008
5. Li,Z., Kienetz,M., Cherney,M.M., James,M.N. and Bromme,D.
   The crystal and molecular structures of a cathepsin K:chondroitin sulfate complex
   J Mol Biol (2008) 383, 78-91. PubMed  Europe PubMed DOI  S
2005
6. [YEAR:1-4-2005]Deaton,D.N., Hassell,A.M., McFadyen,R.B., Miller,A.B., Miller,L.R., Shewchuk,L.M., Tavares,F.X., Willard,D.H., Jr. and Wright,L.L.
   Novel and potent cyclic cyanamide-based cathepsin K inhibitors
   Bioorg Med Chem Lett (1-4-2005) 15, 1815-1819. PubMed  Europe PubMed DOI  S  I
7. [YEAR:1-12-2005]Palmer,J.T., Bryant,C., Wang,D.X., Davis,D.E., Setti,E.L., Rydzewski,R.M., Venkatraman,S., Tian,Z.Q., Burrill,L.C., Mendonca,R.V., Springman,E., McCarter,J., Chung,T., Cheung,H., Janc,J.W., McGrath,M., Somoza,J.R., Enriquez,P., Yu,Z.W., Strickley,R.M., Liu,L., Venuti,M.C., Percival,M.D., Falgueyret,J.P., Prasit,P., Oballa,R., Riendeau,D., Young,R.N., Wesolowski,G., Rodan,S.B., Johnson,C., Kimmel,D.B. and Rodan,G.
   Design and synthesis of tri-ring P3 benzamide-containing aminonitriles as potent, selective, orally effective inhibitors of cathepsin K
   J Med Chem (1-12-2005) 48, 7520-7534. PubMed  Europe PubMed DOI  S  I
2004
8. [YEAR:18-11-2004]Altmann,E., Cowan-Jacob,S.W. and Missbach,M.
   Novel purine nitrile derived inhibitors of the cysteine protease cathepsin K
   J Med Chem (18-11-2004) 47, 5833-5836. PubMed  Europe PubMed DOI  S  I
2003
9. [YEAR:30-12-2003]McGrath,M.E., Sprengeler,P.A., Hill,C.M., Martichonok,V., Cheung,H., Somoza,J.R., Palmer,J.T. and Janc,J.W.
   Peptide ketobenzoxazole inhibitors bound to cathepsin K
   Biochemistry (30-12-2003) 42, 15018-15028. PubMed  Europe PubMed DOI  S  I
1999
10. Sivaraman,J., Lalumiere,M., Menard,R. and Cygler,M.
    Crystal structure of wild-type human procathepsin K
    Protein Sci (1999) 8, 283-290. PubMed  Europe PubMed DOI  PMC  EPMC  S
1998
11. [YEAR:5-11-1998]LaLonde,J.M., Zhao,B., Smith,W.W., Janson,C.A., DesJarlais,R.L., Tomaszek,T.A., Carr,T.J., Thompson,S.K., Oh,H.J., Yamashita,D.S., Veber,D.F. and Abdel-Meguid,S.S.
    Use of papain as a model for the structure-based design of cathepsin K inhibitors: crystal structures of two papain-inhibitor complexes demonstrate binding to S'-subsites
    J Med Chem (5-11-1998) 41, 4567-4576. PubMed  Europe PubMed DOI  S  I
1997
12. McGrath,M.E., Klaus,J.L., Barnes,M.G. and Bromme,D.
    Crystal structure of human cathepsin K complexed with a potent inhibitor
    Nat Struct Biol (1997) 4, 105-109. PubMed  Europe PubMed DOI  S  I
13. Zhao,B., Janson,C.A., Amegadzie,B.Y., D'Alessio,K., Griffin,C., Hanning,C.R., Jones,C., Kurdyla,J., McQueney,M., Qiu,X., Smith,W.W. and Abdel-Meguid,S.S.
    Crystal structure of human osteoclast cathepsin K complex with E-64
    Nat Struct Biol (1997) 4, 109-111. PubMed  Europe PubMed DOI  S